|
1
|
TEKİN M, UZUN ND, UZUN F. Evaluation of ferric carboxymaltose treatment efficacy in women with postpartum iron deficiency anemia. JOURNAL OF HEALTH SCIENCES AND MEDICINE 2021. [DOI: 10.32322/jhsm.800829] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
|
2
|
Strauss WE, Franklin Adkinson N, Macdougall IC, Auerbach M, Kaper RF, Chertow GM, Krop JS. A response by Strauss et al. to "a comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia". Am J Hematol 2018; 93:E232-E233. [PMID: 30016554 DOI: 10.1002/ajh.25200] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2018] [Accepted: 06/15/2018] [Indexed: 11/10/2022]
Affiliation(s)
| | - N Franklin Adkinson
- Johns Hopkins University School of Medicine, University in Baltimore, Baltimore, Maryland
| | - Iain C Macdougall
- Department of Renal Medicine, King's College Hospital, London, United Kingdom
| | | | | | - Glenn M Chertow
- Stanford University School of Medicine, Stanford, California
| | - Julie S Krop
- AMAG Pharmaceuticals, Inc, Waltham, Massachusetts
| |
Collapse
|